Chemomab Therapeutics CMMB
NASDAQ CMMB
$1.16 -0.45 (-27.95%)
As of: Sep 30, 2026 · 2:11 PM EDT

Chemomab Therapeutics Ltd. (CMMB) Retained Earnings (2017 - 2026)

Updated

Chemomab Therapeutics' Retained Earnings was -$115.56 million in Q2 2026, compared with -$108 million a year earlier.

Analysis

Chemomab Therapeutics Ltd. (CMMB) Retained Earnings (2017 - 2026) Analysis & Trends

At the end of FY2025, Retained Earnings at Chemomab Therapeutics came in at -$111.62 million.

  • In earlier years, Retained Earnings was -$102.62 million in FY2024, -$88.68 million in FY2023, -$63.82 million in FY2022 and -$36.17 million in FY2021.
  • The Q2 2026 figure marks the lowest quarterly Retained Earnings in data going back to Q4 2017.
  • Per Business Quant data, CMMB's Retained Earnings in the three quarters before Q2 2026 was -$113.39 million (Q1 2026), -$111.62 million (Q4 2025) and -$109.75 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -115.56 Mn
Mar 31, 2026 -113.39 Mn
Dec 31, 2025 -111.62 Mn
Sep 30, 2025 -109.75 Mn
Jun 30, 2025 -108.00 Mn
Mar 31, 2025 -105.95 Mn
Dec 31, 2024 -102.62 Mn
Sep 30, 2024 -99.66 Mn
Jun 30, 2024 -96.18 Mn
Mar 31, 2024 -92.55 Mn
Dec 31, 2023 -88.68 Mn
Sep 30, 2023 -84.62 Mn
Jun 30, 2023 -80.54 Mn
Mar 31, 2023 -72.57 Mn
Dec 31, 2022 -63.82 Mn
Sep 30, 2022 -55.55 Mn
Jun 30, 2022 -47.47 Mn
Mar 31, 2022 -41.28 Mn
Dec 31, 2021 -36.17 Mn
Sep 30, 2021 -31.14 Mn
API Access

Chemomab Therapeutics Ltd. Retained Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=retained-earnings&ticker=CMMB&period=max&api_key=YOUR_API_KEY